Phreesia Investor Presentation Deck

Quarterly Revenue¹ (FY2019-FY2023²) $24M $10M $9M $5M Q1'19 Phreesia Subscription and Related Services Payment Processing Fees Life Sciences $25M $10M $9M $5M Q2'19 $25M $11M $9M $5M FY 2019 MORE THAN DOUBLED QUARTERLY REVENUE SINCE FISCAL 2019 $26M $13M $9M $5M ¹ Revenue may not add up due to rounding 2 Fiscal year ended January 31; FY2023 only includes Q1'23 $28M $13M $12M Q3'19 Q4'19 Q1'20 $4M $31M $14M $12M $5M Q2'20 $33M $15M $12M $7M $33M FY 2020 $15M $12M $6M Q3'20 Q4'20 2.7x $33M $16M $12M $6M Q1'21 $35M $17M $12M $6M Q2'21 $38M $17M $13M $8M $42M FY 2021 $19M $13M $10M Q3'21 Q4'21 $48M $22M $17M $10M Q1'22 $51M $23M $16M $12M $56M $24M $16M $15M $58M FY 2022 $26M $16M $15M Q2'22 Q3'22 Q4'22 $63M $29M $19M $15M Q1'23 FY 2023 14

View entire presentation